Given our in vitro results, we analyzed as to what extent Ephrin B3, Ephrin A1 and EphA2 were expressed in early stage IA-IB NSCLC tumor specimens (Figure 5, Table 1, Supplementary Table S1). The gene discussed is EFNA1; the disease is neoplasm.